Home › Stocks › TSHA › All Fund Holders
TSHA — TAYSHA GENE THERAPIES INC · All Fund Holders
Funds holding (latest): 41 · Reported value held: $831.69M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Goldman Sachs Group history | Q2 2026 | 22.71M | $154.68M | 0.01% | Add |
| BlackRock Inc history | Q2 2026 | 20.69M | $140.91M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 16.49M | $112.28M | 0.01% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 13.34M | $90.82M | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 13.27M | $72.97M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 6.56M | $44.69M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 4.40M | $29.95M | 0.02% | Reduce |
| Wellington Management Group history | Q2 2026 | 3.98M | $27.07M | 0.01% | Add |
| Casdin Capital history | Q2 2026 | 3.25M | $22.13M | 1.11% | Hold |
| Farallon Capital Management history | Q2 2026 | 2.25M | $15.32M | 0.07% | New |
| Norges Bank Investment Management history | Q2 2026 | 2.23M | $15.21M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 2.23M | $15.16M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 2.20M | $14.99M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 2.13M | $14.48M | 0.01% | Reduce |
| Citadel Advisors history | Q2 2026 | 1.71M | $11.67M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 1.37M | $9.35M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 766.28K | $5.16M | 0.00% | New |
| BNY Mellon history | Q2 2026 | 697.97K | $4.75M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 588.43K | $4.01M | 0.00% | Add |
| Polen Capital Management history | Q2 2026 | 489.22K | $3.33M | 0.03% | Add |
| Moore Capital Management history | Q2 2026 | 358.37K | $2.44M | 0.04% | Add |
| Wells Fargo & Co history | Q2 2026 | 333.31K | $2.27M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 306.91K | $2.09M | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 461.86K | $2.06M | 0.00% | Reduce |
| Renaissance Technologies history | Q1 2026 | 413.20K | $1.85M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 264.38K | $1.80M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 243.38K | $1.66M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 234.72K | $1.60M | 0.00% | Reduce |
| Marshall Wace history | Q3 2025 | 476.87K | $1.56M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 189.33K | $1.29M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 128.76K | $876.88K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 108.21K | $736.89K | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 106.29K | $723.84K | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 104.09K | $708.89K | 0.00% | Add |
| CPP Investments history | Q4 2025 | 68.90K | $378.95K | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 69.00K | $308.08K | 0.00% | Hold |
| Prudential Financial history | Q2 2026 | 39.04K | $265.86K | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 18.33K | $124.86K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 1.05K | $7.17K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 199.49K | $1.36K | 0.00% | Add |
| Lazard Asset Management history | Q4 2024 | 154 | $0 | — | Hold |